The Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.
Eight distinguished individuals from across the United States will assemble to aid in the publication's fulfillment of its editorial mission to educate the medical community on cannabis treatments.
Professor Edvinas Orentas clears the air surrounding the stigma of synthetic cannabinoids.
Eloise Theisen, a board certified Adult Geriatric Nurse Practitioner who specializes in cannabis therapy, shares her unique insight from helping patients.
Jessica Mandile, a Veterans Affairs caregiver, shares her experience helping her husband use medical cannabis as a treatment for his chronic pain.
With the Cannabis SAFE Banking Act heading to the US Senate, cannabis businesses would be able to to work with financial institutions for their business needs.
GreenBroz Inc., has recently announced their latest cannabis processing addition: the Rise-N-Sort System.
In this interview, Josh Wurzer, President of SC Laboratories, delves into the analytical side of the cannabis industry and some of their cannabis paper product study research.
Researchers from Byers Scientific, Iowa State University, and Texas-based odor experts identified the odor of cannabis.
JMCC Group partners with LYPHE Group Limited to serve medical cannabis patients in the United Kingdom.
Recently, researchers performed a study which discovered that a cannabis plant compound inhibited COVID-19 infection in human lung cells.
Cannabis Science and Technology® is pleased to announce the addition of Richard Sams to its editorial advisory board (EAB).
The 5-part program will dive deep into cultivation, extraction, processing, testing, third-party certifications, and more.
Here we take a closer look at the cannabis industry in Canada and speak to several Canadians involved in the industry.
Gretchen Schmidt, Faculty Program Director Criminal Justice Programs & Cannabis Control at Excelsior College, discusses the graduate certificate program offered at her college.
Chase Towery, the COO of Cultivera, discusses his company, the concerns affecting supply management in the cannabis industry, and much more.
Hemp Processing Partners and United Precision Engineering unveiled a new state-of-the-art hemp refinery facility.
Byers Scientific & Manufacturing and Pacific Environmental Analytics have united together to become Byers Scientific (Byers).
The Battlefront Brothers Foundation received approval from the NIH to move forward with studying how medical cannabis can help veterans with PTSD.
Diane Scott, owner-CEO and Chair of JMCC, recently spoke with us about the medical cannabis landscape, the important research her company is involved in, the roles women play in the industry, and more.
A recent study from University Medical Center Hamburg-Eppendorf Department of Neurology showed promising results in Parkinson's disease patients who used medical cannabis to treat symptoms.
Top cannabis establishments in the industry form the US Cannabis Council (USCC) to help landscape the future of cannabis.
Helix Technologies, Inc. and MOR Analytics have announced the unification of their two companies, becoming Forian Inc..
A new initiative called CannaCareers recently launched and is a collective partnership with NYC-based 501c3 Women of Color in Cannabis, Quality Control Analytics, THC Staffing, and Joint Venture & Co.
In this interview, Brian Smith, PhD, founder, CEO, and CTO at Big Sur Scientific, discusses his work with mid-IR spectroscopy to test for total THC & more.
Avicanna Inc., is growing their epilepsy program through a collaboration with University Health Network.
Cannabis Science and Technology® is pleased to announce the addition of Jack Henion to its editorial advisory board (EAB).
For the 2020-2021 season, the National Basketball Association (NBA) has chosen to freeze random cannabis testing on players, limiting their potential risk of exposure to COVID-19.
Congress passes the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act and the Medical Marijuana Research Act in two historic votes, signifying a growing shift toward cannabis legalization.
United Nations hold historic vote announcing cannabis's Schedule IV removal from the 1961 Single Convention on Narcotics.
